Drug
BAY 60-4552 clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2007
How studies write it
Studies that test it under each name
Development codes
Combined with it in one product
Studies by the year they started
3 studies that test it; most in 2010 (2)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2010 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses BAY 60-4552 is read from its arms, and is right about nine times in ten.
Testing it · 3
- Single Dose Escalation Study in Patients With Chronic Heart FailureCompletedPhase 1BayerNCT00565565Written as BAY60-4552
- Clinical Proof-of-concept Study for the Combination BAY60-4552 / Vardenafil for the Treatment of Erectile Dysfunction Not Sufficiently Responsive to Standard Therapy With PDE5 InhibitorsCompletedPhase 2BayerNCT01168817Written as BAY60-4552 plus Vardenafil
- Multiple Dose Escalation Study (14 Days) to Investigate Safety, Tolerability, PK and PD of Vardenafil and BAY60-4552CompletedPhase 1BayerNCT01110590Written as BAY60-4552 + Vardenafil